GF Xinde Investment Management
VC Fund
Guangzhou, China
GF Xinde Investment Management is a VC fund in Guangzhou focused on Manufacturing and E-Commerce. GF Xinde Investment Management Co., Ltd. was established in 2008 through the approval of the China Securities Commission on Direct Investment, with registered capital of RMB 2.3 billion. GF Xinde is one of the leading direct investment brokerages in China. Through a deep understanding of capital markets, known for integrity, professionalservice, and possessing an abundance of industry resources; GF Xinde not only provides strong financial support to investing corporations, but imparts a wealth of advanced management experience and access to a national business network. Supported by the comprehensive strengths of GF Securities, GF Xinde will assist the invested enterprise with establishing a strategic, long-term plan for growth by increasing their management efficiency, building the ideal capital structure, and a strong platform necessary for a successful IPO. All possible types of investments, merger and acquisitions, business, and technical cooperation opportunities will be provided for the invested enterprise. This will ensure the mutual benefits of both the Company and the invested enterprise are financially sound and increase the overall investment value through business synergies.As a direct investment brokerage, GF Xinde provides distinct advantages in regards to investment resources, market research, professional expertise, mergers and acquisitions and IPO experience. As of December 2014, GF Xinde’s accumulated total assets under management exceeded RMB 5 billion, with 16 successful IPOs, ranking first amongst the industry in both scale and number of successful public offerings.Currently, the Company has successfully created a number of diverse management funds: mezzanine funds, merger and acquisition funds, private equity funds, and other investment funds, covering but not limited to a wide range of industries, such as medicine, consumer stocks, and the internet.
- Total investments:
- 149
- Last investment:
- Lead investor:
- 28%
- Fund size:
- $200M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries GF Xinde Investment Management invests in
Stages GF Xinde Investment Management invests in
Countries GF Xinde Investment Management invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
3 more contacts available
Round size
- Angel
- $425k–$1.4M
- Series A
- $1.4M–$42M
- Series B
- $2.8M–$200M
Investment Focus
Industry
- Manufacturing 22 (15%)
- E-Commerce 12 (8%)
- Biotechnology 11 (7%)
- Health Care 10 (7%)
- Information Technology 10 (7%)
Stage
- Series A 40 (27%)
- Series B 28 (19%)
- Angel 14 (9%)
- Series C 11 (7%)
- Seed 9 (6%)
Country
- China 100 (67%)
- United States 7 (5%)
- Hong Kong 1 (1%)
- Luxembourg 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Li Chen
Partner
|
Partner | Total investments: 5 | Find email | |
Xiaoying Mai
Investment Director
|
Investment Director | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Yaozheng Quantum Technology
|
UnitQC is a China‑based quantum technology company focused on trapped‑ion quantum computing systems and related products. | Series A / Aug 03, 2026 | |
Xihu Xinchen
|
Xihu Xinchen is a technology company focusing on the research and development of artificial intelligence services. | Series B / Aug 03, 2026 | |
SeaArt
|
SeaArt is an AI creativity platform that provides tools for generating and editing images, videos, audio, and interactive AI character chats. The service includes text-to-image art generation, text-to-video and image-to-video creation, and an AI chatbot assistant with customizable characters. SeaArt also offers AI audio synthesis with multiplevoices, workflow control through ComfyUI, model training and hosting for Stable Diffusion based models, and swift AI tools for upscaling and filtering media. A built-in community enables sharing, remixing, challenges, and creator incentive programs for monetizing AI-generated works. | $14.7M / Series B / Jul 13, 2026 | |
Xellar Biosystems
|
Xellar Biosystems is a wet artificial intelligence biotechnology company that provides analysis of drug testing and treatment. | $29.5M / Series A / Jun 30, 2026 | |
Degron Therapeutics
|
Degron Therapeutics is a leading platform company in discovery of molecular glue degraders for cancer treatment. | $40M / Series A / May 14, 2026 | |
Nanochap
|
Nanochap is a biomedical technology developed through core chip research and development. They are regarded as one of the forerunners in the field of resolution artificial retina having been involved in the research of this cutting-edge technology since its inception. They enable clients to monitor human physiological parameters and efficientlyanalyze personal health status. | $44M / Venture - Series Unknown / May 06, 2026 | |
|
FangQing Technology
|
Fangqing Technology is a company mainly engaged in multiple areas of the communications equipment and software industry. Its core business activities include software development and sales, software outsourcing services, information system integration services, and computer system services. | $144.5M / Seed / Mar 09, 2026 | |
X Square
|
X Square is a company focused on developing universal embodied large models for robots, aiming to create a universal brain-cerebellum system that offers comprehensive capabilities from perception to action. | Series A / Feb 25, 2026 | |
|
Huafeng Core
|
Huafeng Core is a specialized provider of advanced chip packaging and testing solutions, delivering comprehensive semiconductor services that cover precision packaging technologies, rigorous quality testing, performance validation, and reliability assurance to meet the evolving demands of the global electronics and integrated circuit industries. | $43.4M / Series A / Feb 13, 2026 | |
Xinyaopaike
|
Xinyaopaike is a technology innovation business that specializes in producing high-end pharmaceutical packaging materials and medical devices for domestic and international pharmaceutical and medical device manufacturers. | $14.3M / Series B / Jan 16, 2026 | |
| See all 149 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does GF Xinde Investment Management invest in?
GF Xinde Investment Management invests primarily in Manufacturing, E-Commerce and Biotechnology startups, most often at Series A and Series B stage. Most of the 149 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is GF Xinde Investment Management's check size?
GF Xinde Investment Management typically joins rounds of $425k–$1.4M at Angel, $1.4M–$42M at Series A and $2.8M–$200M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds GF Xinde Investment Management participates in.
How do I contact GF Xinde Investment Management?
Public channels for GF Xinde Investment Management include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at GF Xinde Investment Management?
The team at GF Xinde Investment Management includes Li Chen (Partner) and Xiaoying Mai (Investment Director). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
